Diagnostic and surveillance testing capability for mpox in the EU/EEA, September 2024.

IF 9.9 2区医学 Q1 INFECTIOUS DISEASES

Eurosurveillance Pub Date : 2024-10-01 DOI:10.2807/1560-7917.ES.2024.29.42.2400632

Nina Lagerqvist, Jessica Beser, Tamás Bakonyi, Céline M Gossner, Daniel Palm

引用次数: 0

Abstract

In response to the increasing number of mpox cases caused by monkeypox virus (MPXV) clade I in the African continent and the first reported travel-related clade Ib case of mpox in EU/EEA, the European Centre for Disease Prevention and Control surveyed national capability for detection and characterisation of MPXV in the EU/EEA. The results showed high level of capability for case confirmation by PCR, alongside molecular typing methods for identification of MPXV clades and/or clade I subclades within the EU/EEA.

查看原文本刊更多论文

2024 年 9 月欧盟/欧洲经济区的麻风病诊断和监测检测能力。

鉴于非洲大陆由猴痘病毒（MPXV）I支系引起的痘病例日益增多，以及欧盟/欧洲经济区首次报告与旅行有关的Ib支系痘病例，欧洲疾病预防控制中心对欧盟/欧洲经济区各国检测和鉴定MPXV的能力进行了调查。结果显示，欧盟/欧洲经济区内通过 PCR 和分子分型方法确认病例的能力很强，同时还能识别 MPXV 支系和/或支系 I 亚支系。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Eurosurveillance INFECTIOUS DISEASES-

CiteScore

32.70

自引率

2.10%

发文量

430

审稿时长

3-8 weeks

期刊介绍： Eurosurveillance is a European peer-reviewed journal focusing on the epidemiology, surveillance, prevention, and control of communicable diseases relevant to Europe.It is a weekly online journal, with 50 issues per year published on Thursdays. The journal includes short rapid communications, in-depth research articles, surveillance reports, reviews, and perspective papers. It excels in timely publication of authoritative papers on ongoing outbreaks or other public health events. Under special circumstances when current events need to be urgently communicated to readers for rapid public health action, e-alerts can be released outside of the regular publishing schedule. Additionally, topical compilations and special issues may be provided in PDF format.